AM Best affirms Genworth Financial ratings, revises outlooks to stable

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • AM Best revised outlooks to stable from positive for Genworth Financial Group members
  • FSR of C++ (Marginal) and ICR of "b+" (Marginal) affirmed for GLIC and GLICNY
  • GLAIC ratings affirmed at B- (Fair) FSR and "bb-" (Fair) ICR
  • Weak balance sheet strength offset by adequate BCAR and managed LTC risks
  • Parent companies depend on Enact Holdings dividends to service debt obligations
powered bylight_fuzz_icon
51224788

*this image is generated using AI for illustrative purposes only.

AM Best affirmed the credit ratings of Genworth Financial Group entities and revised their outlooks to stable from positive. The agency maintained its assessment of the group’s balance sheet strength as weak, citing limited business profile and appropriate enterprise risk management.

Rating Actions

The agency affirmed the Financial Strength Rating (FSR) of C++ (Marginal) and Long-Term Issuer Credit Ratings (Long-Term ICR) of "b+" (Marginal) for Genworth Life Insurance Company (GLIC) and Genworth Life Insurance Company of New York (GLICNY).

For Genworth Life and Annuity Insurance Company (GLAIC), AM Best affirmed the FSR of B- (Fair) and Long-Term ICR of "bb-" (Fair). The agency also affirmed the Long-Term ICRs of "bb-" (Fair) for Genworth Financial, Inc. and Genworth Holdings, Inc., along with their respective Long-Term Issue Credit Ratings (Long-Term IRs).

Capitalization and Risk Management

The ratings reflect adequate risk-adjusted capitalization measured by Best’s Capital Adequacy Ratio (BCAR). Although these metrics remain low and volatile, management has maintained them at appropriate levels through actuarially supported premium rate increases and reduced future benefit obligations on in-force long-term care (LTC) policies.

Key financial risks include the timing and effectiveness of premium rate increase approvals and benefit reductions. These factors are critical as the company manages volatility in LTC results and rising claims costs while large blocks approach peak claim years.

Debt Structure

The following Long-Term IRs were affirmed with stable outlooks:

Entity Instrument Rating
Genworth Holdings, Inc. $300 million 6.50% senior unsecured notes, due 2034 "bb-" (Fair)
Genworth Holdings, Inc. $600 million fixed/floating rate junior subordinated notes, due 2066 "b" (Marginal)

Indicative Long-Term IRs for both Genworth Holdings, Inc. and Genworth Financial, Inc. were affirmed at "bb-" (Fair) for senior unsecured debt, "b+" (Marginal) for subordinated debt, and "b" (Marginal) for preferred stock.

What the Numbers Show

Genworth Financial, Inc. and Genworth Holdings, Inc. depend on dividends from Enact Holdings, Inc (NASDAQ: ACT) to service debt obligations. This dependency supports capital allocation priorities, including share repurchases of CareScout and opportunistic debt reduction.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the shift to a stable outlook impact Genworth's ability to refinance its $300 million senior unsecured notes due in 2034?

What are the potential regulatory hurdles for Genworth's planned premium rate increases on in-force long-term care policies?

How significant is the dependency on dividends from Enact Holdings for servicing debt, and what risks does this concentration pose if Enact's performance declines?

like15
dislike

KBW Maintains Outperform on Genworth Financial, Cuts Target to $11.5

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Keefe, Bruyette & Woods maintains Outperform rating on Genworth Financial
  • Price target lowered from $12 to $11.5 by analyst Ryan Krueger
  • Genworth Financial trades on NYSE under ticker GNW
powered bylight_fuzz_icon
51127882

*this image is generated using AI for illustrative purposes only.

Keefe, Bruyette & Woods analyst Ryan Krueger maintained an Outperform rating on Genworth Financial (NYSE: GNW) while lowering the price target from $12 to $11.5.

The adjustment reflects a downward revision in the firm's valuation model for the insurance provider.

Analyst Action Details

Metric Previous Value New Value
Rating Outperform Outperform
Price Target $12 $11.5

Krueger’s decision to retain the bullish stance despite the lower target suggests the underlying business thesis remains intact, albeit at a reduced valuation multiple.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific changes in Genworth's valuation model or macroeconomic assumptions drove the 4% reduction in the price target?

How might this slight downgrade in valuation multiple impact investor sentiment given that the 'Outperform' rating was maintained?

Are there upcoming regulatory developments or capital requirement changes in the insurance sector that could further pressure Genworth's near-term profitability?

like15
dislike

More News on Genworth Financial